相关实验视频
Updated: Jan 7, 2026

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
1.2K
在75岁时,是双极性障碍的黄金标准吗?
1Department of Psychiatry, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva 8410501, Israel.
Pharmaceuticals (Basel, Switzerland)
|December 31, 2025
概括
,抗药和抗精神病药物有效治疗双极性障碍阶段. 然而,它们的多样化机制突出了的存在.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 是双相情绪障碍的第一个情绪稳定剂.
- 抗药物 (例如,酸,卡巴马泽平) 和第二代抗精神病药物也在所有双极性障碍阶段都有效.
- 这些治疗方法缺乏共同的作用机制.
研究的目的:
- 审查,抗药和抗精神病药在双相情感障碍治疗中的疗效和机制.
- 批判性地评估作为"黄金标准"治疗的作用.
主要方法:
- 文献综述和综合现有关于双相情绪障碍情绪稳定剂的研究.
- 分析,抗药和抗精神病药的生化作用和临床应用.
主要成果:
- ,抗药和抗精神病药在两极性障碍阶段表现出相似的疗效.
- 表现出众多的生化作用,但统一的机制仍然难以捉摸.
- 其他药物类别的疗效挑战了的独特地位.
结论:
- 是一种有用的,但不特定的,治疗双相情感障碍和其他疾病.
- 目前的证据不支持将作为"黄金标准",这是由于其他药物的疗效.
- 需要进一步的研究来阐明情绪稳定剂的共同和独特的作用机制.
相关概念视频
Mania and Antimanic Drugs: Overview
526
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
526
Bipolar Disorder
586
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
586
Drug Therapy
229
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
229
Psychosis: Goals of Pharmacotherapy
436
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
436
Electroconvulsive Therapy
780
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
780
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
216
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
216

